We use cookies to improve our services. Read more about how we use cookies and how you can refuse them.
Clinical question: Do supervised injection sites (SISs) reduce mortality,
hospitalizations, ambulance calls, or disease.
Bottom line: Best evidence from cohort and modeling studies suggests that SISs are associated with lower overdose mortality (88 fewer overdose deaths per 100 000 person-years [PYs]), 67% fewer ambulance calls for treating overdoses, and a decrease in HIV infections. Effects on hospitalizations are unknown.
hospitalizations, ambulance calls, or disease.
Bottom line: Best evidence from cohort and modeling studies suggests that SISs are associated with lower overdose mortality (88 fewer overdose deaths per 100 000 person-years [PYs]), 67% fewer ambulance calls for treating overdoses, and a decrease in HIV infections. Effects on hospitalizations are unknown.
Published in 2017
by Jennifer Ng, Christy Sutherland, Michael R. Kolber
English